Seguir
Donna D. Zhang
Donna D. Zhang
Dirección de correo verificada de pharmacy.arizona.edu
Título
Citado por
Citado por
Año
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
13861*2021
Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease
BR Stockwell, JPF Angeli, H Bayir, AI Bush, M Conrad, SJ Dixon, S Fulda, ...
Cell 171 (2), 273-285, 2017
54842017
Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress
DD Zhang, M Hannink
Molecular and cellular biology, 2003
16762003
Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival
SB Cullinan, D Zhang, M Hannink, E Arvisais, RJ Kaufman, JA Diehl
Molecular and cellular biology 23 (20), 7198-7209, 2003
14542003
Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex
DD Zhang, SC Lo, JV Cross, DJ Templeton, M Hannink
Molecular and cellular biology, 2004
14522004
NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
M Dodson, R Castro-Portuguez, DD Zhang
Redox biology 23, 101107, 2019
14332019
The emerging role of the Nrf2–Keap1 signaling pathway in cancer
MC Jaramillo, DD Zhang
Genes & development 27 (20), 2179-2191, 2013
14122013
Mechanistic studies of the Nrf2-Keap1 signaling pathway
DD Zhang
Drug metabolism reviews 38 (4), 769-789, 2006
12962006
NRF2 and the Hallmarks of Cancer
MR de la Vega, E Chapman, DD Zhang
Cancer cell 34 (1), 21-43, 2018
11822018
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
XJ Wang, Z Sun, NF Villeneuve, S Zhang, F Zhao, Y Li, W Chen, X Yi, ...
Carcinogenesis 29 (6), 1235-1243, 2008
9712008
A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62
A Lau, XJ Wang, F Zhao, NF Villeneuve, T Wu, T Jiang, Z Sun, E White, ...
Molecular and cellular biology 30 (13), 3275-3285, 2010
9002010
Dual roles of Nrf2 in cancer
A Lau, NF Villeneuve, Z Sun, PK Wong, DD Zhang
Pharmacological research 58 (5-6), 262-270, 2008
8082008
Direct interaction between Nrf2 and p21Cip1/WAF1 upregulates the Nrf2-mediated antioxidant response
W Chen, Z Sun, XJ Wang, T Jiang, Z Huang, D Fang, DD Zhang
Molecular cell 34 (6), 663-673, 2009
7312009
Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
D Ren, NF Villeneuve, T Jiang, T Wu, A Lau, HA Toppin, DD Zhang
Proceedings of the National Academy of Sciences 108 (4), 1433-1438, 2011
6902011
p62 links autophagy and Nrf2 signaling
T Jiang, B Harder, MR De La Vega, PK Wong, E Chapman, DD Zhang
Free Radical Biology and Medicine 88, 199-204, 2015
5962015
Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy
H Zheng, SA Whitman, W Wu, GT Wondrak, PK Wong, D Fang, DD Zhang
Diabetes 60 (11), 3055-3066, 2011
5742011
The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy
T Jiang, Z Huang, Y Lin, Z Zhang, D Fang, DD Zhang
Diabetes 59 (4), 850-860, 2010
5122010
Regulation of the Nrf2–Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases
NF Villeneuve, A Lau, DD Zhang
Antioxidants & redox signaling 13 (11), 1699-1712, 2010
4592010
Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response
Z Sun, YE Chin, DD Zhang
Molecular and cellular biology, 2009
4442009
Modulating NRF2 in disease: timing is everything
M Dodson, MR de la Vega, AB Cholanians, CJ Schmidlin, E Chapman, ...
Annual review of pharmacology and toxicology 59 (1), 555-575, 2019
4302019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20